Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Gastroenterology & Hepatology
|
May 28, 2016
How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease
Seymour Katz, Gil Melmed
Gastroenterology
|
April 8, 2021
Reply
Gil Melmed, David T Rubin, Dermot McGovern
Surgery
|
April 17, 2012
Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot study
Karen Zaghiyan, Gil Melmed, Zuri Murrell, et al.
The American Surgeon
|
December 1, 2011
Are high-dose perioperative steroids necessary in patients undergoing colorectal surgery treated with steroid therapy within the past 12 months?
Karen Zaghiyan, Gil Melmed, Zuri Murrell, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 4, 2008
Biomarkers and health-related quality of life in end-stage renal disease: a systematic review
Brennan M R Spiegel, Gil Melmed, Sean Robbins, et al.
ACG Case Reports Journal
|
August 14, 2024
Successful Outcome Treating Pyoderma Gangrenosum and Pouchitis With Upadacitinib
Paula Milena Prieto Jimenez, Siamak Tabib, Brook Abbott, et al.
The American Journal of Gastroenterology
|
September 17, 2009
Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis
Yosef Nasseri, Gil Melmed, Hanlin L Wang, et al.
Diseases of the Colon and Rectum
|
February 23, 2010
Preoperative wireless capsule endoscopy does not predict outcome after ileal pouch-anal anastomosis
Zuri Murrell, Eric Vasiliauskas, Gil Melmed, et al.
Diseases of the Colon and Rectum
|
January 14, 2011
Phantom publications among applicants to a colorectal surgery residency program
Yosef Nasseri, Som Kohanzadeh, Zuri Murrell, et al.
Rhode Island Medical Journal (2013)
|
October 27, 2022
Treat-to-Target: The Era of Targeted Immunosuppressive Agents in IBD Management
Daniel Marino, Siddharth Singh, Jason Hou, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Gastroenterology & Hepatology
|
May 28, 2016
How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease
Seymour Katz, Gil Melmed
Gastroenterology
|
April 8, 2021
Reply
Gil Melmed, David T Rubin, Dermot McGovern
Surgery
|
April 17, 2012
Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot study
Karen Zaghiyan, Gil Melmed, Zuri Murrell, et al.
The American Surgeon
|
December 1, 2011
Are high-dose perioperative steroids necessary in patients undergoing colorectal surgery treated with steroid therapy within the past 12 months?
Karen Zaghiyan, Gil Melmed, Zuri Murrell, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 4, 2008
Biomarkers and health-related quality of life in end-stage renal disease: a systematic review
Brennan M R Spiegel, Gil Melmed, Sean Robbins, et al.
ACG Case Reports Journal
|
August 14, 2024
Successful Outcome Treating Pyoderma Gangrenosum and Pouchitis With Upadacitinib
Paula Milena Prieto Jimenez, Siamak Tabib, Brook Abbott, et al.
The American Journal of Gastroenterology
|
September 17, 2009
Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis
Yosef Nasseri, Gil Melmed, Hanlin L Wang, et al.
Diseases of the Colon and Rectum
|
February 23, 2010
Preoperative wireless capsule endoscopy does not predict outcome after ileal pouch-anal anastomosis
Zuri Murrell, Eric Vasiliauskas, Gil Melmed, et al.
Diseases of the Colon and Rectum
|
January 14, 2011
Phantom publications among applicants to a colorectal surgery residency program
Yosef Nasseri, Som Kohanzadeh, Zuri Murrell, et al.
Rhode Island Medical Journal (2013)
|
October 27, 2022
Treat-to-Target: The Era of Targeted Immunosuppressive Agents in IBD Management
Daniel Marino, Siddharth Singh, Jason Hou, et al.
Page
of 3